12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

GLPG0974: Phase I started

Galapagos began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate multiple ascending-doses of oral GLPG0974 for 2 weeks...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >